Arteaga CL - Search Results

1

Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.

Come SE, Buzdar AU, Arteaga CL, Brodie AM, Davidson NE, Dowsett M, Ingle JN, Johnston SR, Lee AV, Osborne CK, Pritchard KI, Vogel VG, Winer EP, Hart CS. Come SE, et al. Among authors: arteaga cl. Clin Cancer Res. 2003 Jan;9(1 Pt 2):443S-6S. Clin Cancer Res. 2003. PMID: 12538498 Review. No abstract available.

2

Growth factors as mediators of estrogen/antiestrogen action in human breast cancer cells.

Arteaga CL, Osborne CK. Arteaga CL, et al. Cancer Treat Res. 1991;53:289-304. doi: 10.1007/978-1-4615-3940-7_14. Cancer Treat Res. 1991. PMID: 1672083 Review. No abstract available.

3

Regulation of breast cancer growth by insulin-like growth factors.

Osborne CK, Clemmons DR, Arteaga CL. Osborne CK, et al. Among authors: arteaga cl. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):805-9. doi: 10.1016/0960-0760(90)90423-i. J Steroid Biochem Mol Biol. 1990. PMID: 2178363

4

Autocrine and paracrine growth regulation of breast cancer: clinical implications.

Osborne CK, Arteaga CL. Osborne CK, et al. Among authors: arteaga cl. Breast Cancer Res Treat. 1990 Jan;15(1):3-11. doi: 10.1007/BF01811884. Breast Cancer Res Treat. 1990. PMID: 2183891 Review.

5

Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.

Arteaga CL, Osborne CK. Arteaga CL, et al. Cancer Res. 1989 Nov 15;49(22):6237-41. Cancer Res. 1989. PMID: 2553250

6

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, Osborne CK. Arteaga CL, et al. J Clin Invest. 1989 Nov;84(5):1418-23. doi: 10.1172/JCI114315. J Clin Invest. 1989. PMID: 2553774 Free PMC article.

7

Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens.

Osborne CK, Kitten L, Arteaga CL. Osborne CK, et al. Among authors: arteaga cl. J Clin Oncol. 1989 Jun;7(6):710-7. doi: 10.1200/JCO.1989.7.6.710. J Clin Oncol. 1989. PMID: 2715802

8

Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK. Arteaga CL, et al. Cancer Res. 1988 Jul 15;48(14):3898-904. Cancer Res. 1988. PMID: 3164252

9

Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.

Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, Von Hoff DD. Arteaga CL, et al. Cancer Res. 1988 Sep 1;48(17):5023-8. Cancer Res. 1988. PMID: 3165707

10

Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer.

Arteaga CL, Coronado E, Osborne CK. Arteaga CL, et al. Mol Endocrinol. 1988 Nov;2(11):1064-9. doi: 10.1210/mend-2-11-1064. Mol Endocrinol. 1988. PMID: 3221874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters